• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Acquired perforating dermatosis associated with risankizumab.

作者信息

Alhadlg Munira, Alhammad Ghadah, Madani Abdulaziz

机构信息

Department of Dermatology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

出版信息

JAAD Case Rep. 2024 Feb 2;45:88-90. doi: 10.1016/j.jdcr.2024.01.023. eCollection 2024 Mar.

DOI:10.1016/j.jdcr.2024.01.023
PMID:38434600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10907506/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca6/10907506/3fac824f69bf/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca6/10907506/0a2327d1da79/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca6/10907506/47fb7e919825/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca6/10907506/3fac824f69bf/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca6/10907506/0a2327d1da79/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca6/10907506/47fb7e919825/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca6/10907506/3fac824f69bf/gr3.jpg

相似文献

1
Acquired perforating dermatosis associated with risankizumab.与司库奇尤单抗相关的获得性穿通性皮肤病
JAAD Case Rep. 2024 Feb 2;45:88-90. doi: 10.1016/j.jdcr.2024.01.023. eCollection 2024 Mar.
2
Acquired perforating dermatosis: clinicopathological features in twenty-two cases.获得性穿通性皮肤病：22例临床病理特征
J Eur Acad Dermatol Venereol. 2006 Jul;20(6):679-88. doi: 10.1111/j.1468-3083.2006.01571.x.
3
Acquired perforating dermatosis successfully treated with photodynamic therapy.获得性穿孔性皮肤病经光动力疗法治疗后获得成功。
Photodermatol Photoimmunol Photomed. 2012 Feb;28(1):50-2. doi: 10.1111/j.1600-0781.2011.00634.x.
4
Dupilumab in acquired perforating dermatosis: A potential new treatment.度普利尤单抗治疗获得性穿通性皮肤病：一种潜在的新疗法。
JAAD Case Rep. 2022 Aug 11;28:34-36. doi: 10.1016/j.jdcr.2022.08.013. eCollection 2022 Oct.
5
Giant variant of acquired perforating dermatosis in a renal dialysis patient.一名肾透析患者的获得性穿通性皮肤病巨变体
JAAD Case Rep. 2017 Jan 31;3(1):42-44. doi: 10.1016/j.jdcr.2016.10.004. eCollection 2017 Jan.
6
Acquired Perforating Dermatosis as a Paraneoplastic Feature: A Case Report, Literature Review, and Novel Association.获得性穿通性皮肤病作为副肿瘤性特征：一例报告、文献综述及新关联
Case Rep Nephrol Dial. 2023 Jun 20;13(1):36-44. doi: 10.1159/000530756. eCollection 2023 Jan-Dec.
7
Acquired perforating dermatosis: comparison of an acquired perforating dermatosis and perforation as an incidental histologic finding.获得性穿通性皮肤病：获得性穿通性皮肤病与作为偶然组织学发现的穿孔的比较。
J Dermatol. 1990 Aug;17(8):493-9. doi: 10.1111/j.1346-8138.1990.tb01682.x.
8
Acquired Reactive Perforating Collagenosis: A Case Report.获得性反应性穿孔性胶原病：一例报告
Cureus. 2021 Feb 27;13(2):e13583. doi: 10.7759/cureus.13583.
9
Cabozantinib-associated acquired perforating dermatosis.卡博替尼相关的获得性穿通性皮肤病。
JAAD Case Rep. 2024 Jun 14;52:38-41. doi: 10.1016/j.jdcr.2024.06.002. eCollection 2024 Oct.
10
Effective treatment of uremic pruritus and acquired perforating dermatosis with amitriptyline.阿米替林有效治疗尿毒症性瘙痒和获得性穿通性皮肤病。
Australas J Dermatol. 2014 Aug;55(3):e54-7. doi: 10.1111/ajd.12026. Epub 2013 Feb 21.

本文引用的文献

1
Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis.在中重度斑块状银屑病患者的 17 项临床试验中评估 risankizumab 的长期安全性。
Br J Dermatol. 2022 Mar;186(3):466-475. doi: 10.1111/bjd.20818. Epub 2021 Nov 24.
2
Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review.IL-23 抑制剂治疗斑块状银屑病和银屑病关节炎：全面综述。
Am J Clin Dermatol. 2021 Mar;22(2):173-192. doi: 10.1007/s40257-020-00578-0.
3
Perforating disorder secondary to leflunomide and review of the literature of medications associated with perforating disorder.
来氟米特继发的穿孔性疾病及与穿孔性疾病相关药物的文献综述
Dermatol Online J. 2018 May 15;24(5):13030/qt6167g2vr.
4
A clinicopathologic study of thirty cases of acquired perforating dermatosis in Korea.韩国30例获得性穿通性皮肤病的临床病理研究。
Ann Dermatol. 2014 Apr;26(2):162-71. doi: 10.5021/ad.2014.26.2.162. Epub 2014 Apr 30.
5
Acquired perforating dermatosis: clinicopathological features in twenty-two cases.获得性穿通性皮肤病：22例临床病理特征
J Eur Acad Dermatol Venereol. 2006 Jul;20(6):679-88. doi: 10.1111/j.1468-3083.2006.01571.x.
6
Perforating folliculitis: report of a case in an HIV-infected man.穿通性毛囊炎：1例HIV感染男性病例报告。
J Am Acad Dermatol. 1999 Feb;40(2 Pt 2):300-2. doi: 10.1016/s0190-9622(99)70470-6.
7
Acquired perforating dermatosis in renal and diabetic patients.
Lancet. 1997 Mar 29;349(9056):895-6. doi: 10.1016/s0140-6736(05)62693-1.
8
Acquired reactive perforating collagenosis. Report of six cases and review of the literature.获得性反应性穿通性胶原病。6例报告及文献复习。
J Am Acad Dermatol. 1994 Apr;30(4):575-80. doi: 10.1016/s0190-9622(94)70065-6.
9
Reactive perforating collagenosis in Hodgkin's disease.
Am J Dermatopathol. 1987 Feb;9(1):41-4. doi: 10.1097/00000372-198702000-00009.
10
Acquired perforating dermatosis. Evidence for combined transepidermal elimination of both collagen and elastic fibers.获得性穿通性皮肤病。胶原蛋白和弹性纤维经表皮联合清除的证据。
Arch Dermatol. 1989 Aug;125(8):1074-8. doi: 10.1001/archderm.125.8.1074.